Condition
GPC3 Positive Hepatocellular Carcinoma clinical trials and research
Research outlook What's coming for Liver cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 GPC3 Positive Hepatocellular Carcinoma clinical trials that are recruiting, in China. By phase: Phase 1 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Super CAR-T therapy for GPC3-positive advanced liver cancer
This trial tests a single infusion of Super CAR-T cell therapy in adults with advanced, GPC3-positive hepatocellular carcinoma who have failed at least two standard treatments.
-
TC-G203 treatment for GPC3-positive advanced solid tumors
This trial will test a single-dose TC-G203 cell therapy to see if it is safe and helps adults with GPC3-positive recurrent or metastatic solid tumors who have already tried other treatments.
Related topics
Quick answers
How many GPC3 Positive Hepatocellular Carcinoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.